SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-071187
Filing Date
2023-06-14
Accepted
2023-06-14 16:07:38
Documents
13
Period of Report
2023-06-09
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2318622d1_8k.htm   iXBRL 8-K 46374
2 EXHIBIT 3.2 tm2318622d1_ex3-2.htm EX-3.2 5820
  Complete submission text file 0001104659-23-071187.txt   230311

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA regn-20230609.xsd EX-101.SCH 3036
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE regn-20230609_lab.xml EX-101.LAB 34476
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE regn-20230609_pre.xml EX-101.PRE 22597
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2318622d1_8k_htm.xml XML 3632
Mailing Address 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591
Business Address 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 9148477000
REGENERON PHARMACEUTICALS, INC. (Filer) CIK: 0000872589 (see all company filings)

IRS No.: 133444607 | State of Incorp.: NY | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19034 | Film No.: 231014164
SIC: 2834 Pharmaceutical Preparations